Veeva Systems Inc. has announced that Merck, also known as MSD outside the United States and Canada, has committed to using Veeva Vault CRM. This strategic move is set to support Merck as it embarks on one of its most significant launch periods, spanning various new therapeutic areas and modalities. Dave Williams, Merck's executive vice president and chief information and digital officer, expressed excitement about expanding the partnership with Veeva, highlighting the shared commitment to customer success. Veeva CEO Peter Gassner praised Merck's leadership in science and expressed honor in extending their partnership to include Vault CRM. The Vault CRM solution, part of the Vault CRM Suite, offers advanced global capabilities tailored to meet unique regional and compliance requirements, enhancing commercial execution across both personal and digital channels.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.